FDA Approves TOFIDENCE™ (tocilizumab-bavi) a Biosimilar of ACTEMRA® developed by Bio-Thera Solutions ...Middle East

TOFIDENCE is Bio-Thera's first product approved by USFDA. TOFIDENCE is the first monoclonal antibody drug researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States TOFIDENCE is the first biosimilar to Actemra approved by USFDA...

Hence then, the article about fda approves tofidence tocilizumab bavi a biosimilar of actemra developed by bio thera solutions was published today ( Sunday 08/10/2023 - 11:56 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves TOFIDENCE™ (tocilizumab-bavi) a Biosimilar of ACTEMRA® developed by Bio-Thera Solutions )

Also on site :

• The New Infrastructure of Social Growth: Why SaaS Startups Are Moving Beyond Emulators with GeeLark Cloud Phone
• Kremlin responds to ‘borderline crazy’ threat from NATO state
• This Landmark Was Just Ranked ‘Most Loved in the World’—and It's Not the Eiffel Tower